A DESCRIPTIVE STUDY OF IMMEDIATE CAUSE OF DEATH IN COVID-19 HOSPITAL DEATH REPORTED AT TERTIARY CARE HOSPITAL IN WESTERN MAHARASHTRA.

Authors

  • T Anandhakrishnan Junior Resident, Department of Forensic Medicine & Toxicology, Armed Forces Medical College, Pune Author
  • Rashid Nehal Khan Associate Professor, Department of Forensic Medicine & Toxicology, Armed Forces Medical College, Pune Author
  • M Sarala Associate Professor, Department of Forensic Medicine & Toxicology, Army college of Medical Science, Delhi. Author
  • Sandeep Bansal Assistant Professor, Department of Forensic Medicine & Toxicology, Command Hospital Southern Command, Pune. Author
  • K V Radhakrishna Professor and Head of Department, Department of Forensic Medicine & Toxicology, Armed Forces Medical College, Pune. Author
  • Chetna Pandey Assistant Professor, Department of Microbiology, Command Hospital Central Command, Lucknow. Author
  • Thippesh Kumar Associate Professor, Department of Forensic Medicine & Army college of Medical Science, Delhi. Author

Keywords:

COVID-19, Co-morbidities, Antecedent cause, Immediate cause

Abstract

Background: The Coronavirus Disease 2019 (COVID 19) pandemic has had serious worldwide consequences. Even though the disease can affect any age group, the elderly individuals and patients with comorbidities are at risk for severe disease. AIM: The aim of the study is to study Immediate Cause of Death in Covid-19 Hospital Death reported at Tertiary Care Hospital in Western Maharashtra. Methodology: The patient demographic profile was collected from hospital admission slip. Duration ofimmediate cause and antecedent cause of death were noted from the Medical certificate of cause of death. Total of 434 COVID 19 death reported during the period. Results: Out of 434 patients, 28.8% death were seen in age group of 61 to 70 years, 66.8% of death were seen in male and 33.2% in female. The duration of hospital stay was shorter in COVID-19 deaths with co-morbidities. The highest number of deaths were about 164 patients between 1 to 7 days. COVID-19 pneumonia and Acute Respiratory Distress Syndrome contributed to 51.4% and 33.2% deaths respectively in immediate cause of death. COVID-19 pneumonia and COVID-19 infection contributed about 129 and 26 deaths respectively. Among co-morbidities, 50.2% patients had hypertension, and 39.9% patients had diabetes mellitus and 29.5% patients had both hypertension and diabetes mellitus Conclusion: Recording of co-morbidities throughout hospitalization may help as a guideline to develop risk stratification and management of patients with COVID 19 to reduce overall mortality.

Downloads

Download data is not yet available.

References

Pezzullo AM, Axfors C, Contopoulos-Ioannidis DG, Apostolatos A, Ioannidis JPA. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023 Jan 1;216(Pt 3):114655.

Dong, E., Du, H. & Gardner, L. An interactive web based dashboard to track COVID-19 in real time. Lancet Infect. Dis. May 20(5), 533–534.

Mave V, Shaikh A, Monteiro JM, Bogam P, Pujari BS, Gupte N. Association of national and regional lockdowns with COVID-19 infection rates in Pune, India. Sci Rep. 2022 Jun 21;12(1):10446.

Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC public health. 2020 Dec;20(1):1-7.

Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID 19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; Apr 7;323(13):1239-1242.

CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346.

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020 May 29;12(10):9959-9981.

Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021 Jan 12;11:571416.

Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep. 2021 Mar 18;11(1):6375.

Pawar PN, Chavan SS, Jadhao VF, Adsul BB, Kumbhar MA, Dhikale PT, Gokhale CN, Ingale AR. Death analysis of COVID-19 patients admitted indedicated COVID hospital in Mumbai. Journal of Family Medicine and Primary Care. 2022 Apr;11(4):1322.

Keerthi BY, Saritha K, Shah C, Thomas V, Cheryala V. Immediate and antecedent causes of mortality in hospitalised Indian patients with COVID-19. Bioinformation. 2022 Apr 30;18(4):402-410.

Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020 Mar 24;8(1):e35.

Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population based studies. Lancet Diabetes Endocrinol. 2016 Feb;4(2):148-58.

Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020 Apr 8;12(7):6049-6057.

Published

2023-12-25

How to Cite

A DESCRIPTIVE STUDY OF IMMEDIATE CAUSE OF DEATH IN COVID-19 HOSPITAL DEATH REPORTED AT TERTIARY CARE HOSPITAL IN WESTERN MAHARASHTRA. (2023). Journal of Forensic Medicine & Toxicology, 40(2), 89-93. https://jfmtonline.com/index.php/jfmt/article/view/50